Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Parvalbumin alpha ELISA Kit (AC3940)
Cat.#: ASET-2529
Specifications
Description Rat Parvalbumin alpha ELISA Kit allows for the in vitro quantitative determination of rat Parvalbumin alpha concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2093 Human HEXA ELISA Kit (AC3504) Quantitative inquiry ASET-1743 Human TMPRSS2 ELISA Kit (AC3154) Quantitative inquiry ASET-1774 Bovine Ghrelin ELISA Kit (AC3185) Quantitative inquiry ASET-1560 Rat Cathepsin B ELISA Kit (AC2971) Quantitative inquiry ASET-1639 Human Ataxin 1 ELISA Kit (AC3050) Quantitative inquiry ASET-1898 Monkey beta Nerve Growth Factor ELISA Kit (AC3309) Quantitative inquiry ASET-1461 Mouse MT3 ELISA Kit (AC2872) Quantitative inquiry ASET-1355 Human Prion Protein PrP ELISA Kit (AC2766) Quantitative inquiry ASET-1921 Mouse Semaphorin 3c ELISA Kit (AC3332) Quantitative inquiry ASET-1873 Mouse Sprn ELISA Kit (AC3284) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket